DOI: 10.12890/2020_001938

Late Worsening of COVID-19 Pneumonia: Successful Treatment with Ruxolitinib and Steroid

Authors

  • Mauro Betelli Medicina Generale, Bolognini Hospital, ASST Bergamo Est, Seriate, Italy
  • Fabio De Stefano Medicina Generale, Bolognini Hospital, ASST Bergamo Est, Seriate, Italy
  • Alberto Tedeschi Medicina Generale, Bolognini Hospital, ASST Bergamo Est, Seriate, Italy

mauro.betelli@asst-bergamoest.it

Keywords

COVID-19, ruxolitinib, Janus kinase inhibitors

Abstract

We describe the case of a patient hospitalized for the second time in a month due to delayed worsening of lung lesions in COVID-19 infection without bacterial superinfection. He was treated with hydroxychloroquine, IV dexamethasone and ruxolitinib with rapid improvement of respiratory failure; 1 month after the second discharge, maintaining low-dose oral prednisone, lung consolidations were significantly reduced on control CT.

View the entire article

Downloads

References

  1. Matricardi PM, Dal Negro RW, Nisini R. The first, holistic immunological model of COVID-19: implications for prevention, diagnosis, and public health measures. Pediatr Allergy Immunol 2020; 31(5): 454-470.
  2. Siddiqi HK, Mehra MR. COVID-19 illness in native and immunosuppressed states: a clinical-therapeutic staging proposal. J Heart Lung Transplant 2020;39(5):405–407.
  3. Portsmore S, Tran Nguyen TN, Beacham E, Neelakantan P. Combined IL-6 and JAK-STAT inhibition therapy in COVID-19 related sHLH, potential game changer. Br J Haematol 2020;190(4):525–528.
  4. Capochiani E, Frediani B, Iervasi G, Paolicchi A, Sani S, Roncucci P, et al. Ruxolitinib rapidly reduces acute respiratory distress syndrome in COVID-19 disease. Analysis of data collection from RESPIRE protocol. Front Med (Lausanne) 2020;7:466.
  5. La Rosée F, Bremer HC, Gehrke I, Kehr A, Hochhaus A, Birndt S, et al. The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19 with severe systemic hyperinflammation. Leukemia 2020;34(7):1805–1815.

Published

2020-10-14

Issue

Vol. 7 No. 11 (2020)

Categories

How to Cite

1.
Betelli M, De Stefano F, Tedeschi A. Late Worsening of COVID-19 Pneumonia: Successful Treatment with Ruxolitinib and Steroid. EJCRIM [Internet]. 2020 Oct. 14 [cited 2026 Nov. 3];7(11). Available from: https://ejcrim.com/index.php/ejcrim/article/view/1938

Most read articles by the same author(s)